Caris Life Sciences, Inc. Common Stock (CAI) — Quality & forensics
As of 2026-11-16 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 24
- Quality 52
- Growth 60
- Balance sheet 72
- Cash quality 83
- Capital allocation 12
- Momentum 69
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the CAI chart & overview · the earnings record
FAQ · from the current data · as of 2026-11-16
Quick answers
What is Caris Life Sciences, Inc. Common Stock's Closelooknet quality reading?
The composite reads 53/100 across 7 modules, as of 2026-11-16: valuation 24, quality 52, growth 60, balance sheet 72, cash quality 83, capital allocation 12, momentum 69. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Caris Life Sciences, Inc. Common Stock's Altman Z-Score?
6.63, which sits in the safe zone (above 2.99) as of 2026-11-16. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Caris Life Sciences, Inc. Common Stock's Piotroski F-Score?
6 of 9, as of 2026-11-16. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Caris Life Sciences, Inc. Common Stock's Beneish M-Score indicate?
-4.42 — below the −1.78 manipulation-risk threshold, as of 2026-11-16. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- PTGX Protagonist Therapeutics Incindustry
- BION.SW BB Biotech AGindustry
- REPL Replimune Group Incindustry
- VCEL Vericel Corp Ordindustry
- VRDN Viridian Therapeutics Incindustry
- KOD Kodiak Sciences Incindustry
- XNCR Xencor Incindustry
- ADMA ADMA Biologics Incindustry
- MAZE Maze Therapeutics, Inc. Common Stockindustry
- REGN Regeneron Pharmaceuticals Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- MEDCL.PA Medincell SAindustry
- NEU.AU Neuren Pharmaceuticals Ltdindustry
- RPRX Royalty Pharma Plcindustry
- ONC BeOne Medicines AGindustry
- RYTM Rhythm Pharmaceuticals Incindustry